Pervasis is a clinical stage company developing breakthrough therapies with the potential to improve outcomes following vascular procedures. Learn more
Our therapies build on the ability of the body's endothelium to regulate natural healing processes. Learn more
NEWS + EVENTS
April 12, 20112
Press Release
"Shire Adds New Technology Platform & Phase 2 Product Candidate to Regenerative Medicine Business"
April 12, 2012
Fierce Biotech
"Shire picks up Pervasis in potential $200M deal"







